Loading clinical trials...
Loading clinical trials...
Optimal Detection of Atrial Fibrillation in Transient Ischemic Attack
Conditions
Interventions
Subcutaneously implanted event recorder (REVEAL LINQ)
28-day non-invasive continuous ECG monitoring (patch)
Locations
27
Germany
Universitätsklinikum Aachen, Neurologie
Aachen, Germany
Rhön Klinikum Campus Bad Neustadt
Bad Neustadt an der Saale, Germany
Vivantes Klinikum Neukölln
Berlin, Germany
Carl-Thiem-Klinikum Cottbus; Klinik für Neurologie
Cottbus, Germany
Klinikum Dortmund, Klinikzentrum Mitte / Neurologie
Dortmund, Germany
Alfried Krupp Krankenhaus
Essen, Germany
Start Date
March 12, 2019
Primary Completion Date
March 15, 2024
Completion Date
August 31, 2025
Last Updated
February 9, 2026
NCT05147792
NCT06935591
NCT05963698
NCT03546374
NCT04947657
NCT06686485
Lead Sponsor
Alfried Krupp Krankenhaus
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions